Advertisement
Advertisement
CAI
C
Caris Life Sciences, Inc. Common Stock
16.51
USDSponsored
+0.02
+0.10%
Jun 08, 13:04 UTC -4
Open
CAI Earnings Reports
Positive Surprise Ratio
CAI beat 3 of 4 last estimates.
75%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$240.68M
/$0.01
Implied change from Q1 26 (Revenue/ EPS)
+11.34%
/--
Implied change from Q2 25 (Revenue/ EPS)
+32.68%
/-100.13%
Caris Life Sciences, Inc. Common Stock earnings per share and revenue
On May 07, 2026, CAI reported earnings of 0.00 USD per share (EPS) for Q1 26, beating the estimate of -0.02 USD, resulting in a 100.00% surprise. Revenue reached 216.17 million, compared to an expected 212.39 million, with a 1.78% difference. The market reacted with a -18.60% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of 0.01 USD, with revenue projected to reach 240.68 million USD, implying an -- of --% EPS, and increase of 11.34% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Icon Plc
Report Date
May 27, 2026 For Q4 25
Estimate
$3.18
Actual
$2.52
Surprise
-20.85%
HealthEquity, Inc
Report Date
May 28, 2026 For Q1 27
Estimate
$1.12
Actual
$1.24
Surprise
+10.10%
INVO Fertility, Inc. Common Stock
Report Date
Jun 02, 2026 For Q4 25
Estimate
-$2.77
Actual
-$196.81
Surprise
-6985.87%
FAQ
What were Caris Life Sciences, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Caris Life Sciences, Inc. Common Stock reported EPS of $0.00, beating estimates by 100%, and revenue of $216.17M, 1.78% above expectations.
How did the market react to Caris Life Sciences, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -18.6%, changed from $19.84 before the earnings release to $16.15 the day after.
When is Caris Life Sciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Caris Life Sciences, Inc. Common Stock's next earnings report?
Based on --
analysts, Caris Life Sciences, Inc. Common Stock is expected to report EPS of $0.01 and revenue of $240.68M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement